Overview
Neha Mehta-Shah is an Oncologist in Saint Louis, Missouri. Dr. Mehta-Shah has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration. Dr. Mehta-Shah is currently accepting new patients.
Her clinical research consists of co-authoring 79 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Chronic T-Cell Leukemia (CTCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10 Barnes W Dr, Saint Louis, MO 63141
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
18 Clinical Trials
Washington University
Amanda Cashen is an Oncologist in Saint Louis, Missouri. Dr. Cashen is rated as an Elite provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Colonoscopy. Dr. Cashen is currently accepting new patients.
Ssm Health Care Group
William Moriconi is an Oncologist and a Hematologist in Saint Louis, Missouri. Dr. Moriconi has been practicing medicine for over 46 years and is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Pleuropulmonary Blastoma, Small Lymphocytic Lymphoma (SLL), Myeloproliferative Neoplasms (MPN), and Lung Cancer. Dr. Moriconi is currently accepting new patients.
Van Amburg And Busiek Mds LLC
Mark Fesler is a Hematologist Oncology specialist and a Transplant Surgeon in Chesterfield, Missouri. Dr. Fesler is rated as a Distinguished provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Transplant. Dr. Fesler is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Anaplastic Large Cell LymphomaDr. Mehta-Shah isElite. Learn about Anaplastic Large Cell Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Mehta-Shah isElite. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaDr. Mehta-Shah isElite. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Mehta-Shah isElite. Learn about Peripheral T-Cell Lymphoma.
- T-Cell LymphomaDr. Mehta-Shah isElite. Learn about T-Cell Lymphoma.
- Distinguished
- Angioimmunoblastic T-cell LymphomaDr. Mehta-Shah isDistinguished. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Mehta-Shah isDistinguished. Learn about B-Cell Lymphoma.
- Follicular LymphomaDr. Mehta-Shah isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaDr. Mehta-Shah isDistinguished. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Mehta-Shah isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Mehta-Shah isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- Burkitt LymphomaDr. Mehta-Shah isAdvanced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Mehta-Shah isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Mehta-Shah isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Classical Hodgkin LymphomaDr. Mehta-Shah isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Gastric LymphomaDr. Mehta-Shah isAdvanced. Learn about Gastric Lymphoma.
- Lymphofollicular HyperplasiaDr. Mehta-Shah isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Experienced
- AgranulocytosisDr. Mehta-Shah isExperienced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Mehta-Shah isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Mehta-Shah isExperienced. Learn about Breast Cancer.
- Chronic Familial NeutropeniaDr. Mehta-Shah isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic T-Cell Leukemia (CTCL)Dr. Mehta-Shah isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Familial Prostate CancerDr. Mehta-Shah isExperienced. Learn about Familial Prostate Cancer.